57
Growth Score
pts
Heat Score
-20 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
419820
BreakBio develops personalized cancer vaccines using AI, focusing on metastatic cancers.
- Roy deSouza: Co-Founder and CEOPast Role: ZEDO, Founder and CEO
About the Company
BreakBio specializes in the development of personalized vaccines targeting various types of cancers, with an initial focus on metastatic cancers. Utilizing a proprietary, patent-pending treatment approach, BreakBio combines the power of AI Drug Discovery, personalized medicine, and immunotherapy to innovate in the field of cancer treatment. The
company's efforts are directed towards creating breakthrough solutions in cancer prevention and treatment by harnessing the potential of artificial intelligence to analyze each patient's cancer cells, aiming to offer more tailored and effective therapeutic options.
